William gedale

• Developed strategic initiatives to enhance organizational effectiveness and operational efficiency.
• Raised funds to create the company and used my experience in healthcare investing to help corporate visibility

My key role is to advise the CEO strategically and ease the interaction between the CEO and the key scientist.I have known both for many years.

I direct our efforts through our attorneys both in the United States and in Europe to pursue breaches in our patented technology in the messenger RNA domain.

I continue to advise on existing NGN investments

I was one of three founding partners of NGN Capital,a global healthcare venture fund .I was co -leader of analysis and investment.

Managing Accounts for 10 high net worth individuals.My investment strategy was longer term growth opportunities with a bottoms up approach.

Advised on various opportunities in healthcare and helped facilitate the Warburg investment in Zymogenetics which was subsequently sold to Bristol Myers for $140MM

I directed a 30 person staff and managed over $1 billion in assets of the closed end fund and outside accounts.Our approach was longer term investing(3-5Years) and bottoms up research.We also in vested i some private companies.One of our public investments,Sandoz led us to make introductions for Scripps Research and the Neuroscience Institute.In turn this resulted in a $300MM investment by Sandoz in Scripps and a $75MM investment in the Neuroscience Institute.

Over the years I covered healthcare,capital goods,distribution companies and retail goods.I was President of the Machinery Analysts of NY and a member of the Healthcare Analysts.I was also a meber of the New York Society of Security Analysts.